Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
2 Unstoppable Artificial Intelligence (AI) Stocks to Buy in April and 1 to Avoid
While two AI leaders with undeniable competitive moats are historically cheap, another Wall Street darling is staring down a ...
Alphabet Is A Massive Cash Flow Machine With An Under-Leveraged Balance Sheet: Analyst
WestPark Capital initiated coverage on Alphabet with a Buy rating and $210 price target. Despite missing Q4 estimates, ...
Alphabet: Progress In AI Cannot Be Ignored For Long
Alphabet's recent AI progress and Waymo expansion signal growth potential. Learn why GOOG stock is trading cheap and could be ...
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Alphabet Inc. (GOOG): Among the Best US Stocks to Buy For Foreign Investors
We recently published a list of 10 Best US Stocks To Buy For Foreign Investors. In this article, we are going to take a look ...
Alphabet: Poised For Explosive Returns After Selloff
Alphabet's diverse, high-margin growth engines like AI, Cloud & YouTube drive strong revenue growth. Click here to read my ...
Crunchbase News2d
Alphabet-Backed Isomorphic Labs Raises $600M For AI Drug Development
Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...